Michael Pensiero

Title: Michael Pensiero: Innovator in Retroviral Vector Technology

Introduction

Michael Pensiero is a notable inventor based in Dickerson, MD (US). He has made significant contributions to the field of gene therapy, particularly through his work on retroviral vectors. With a total of 2 patents, his innovations have the potential to advance medical treatments and gene delivery systems.

Latest Patents

Michael Pensiero's latest patents focus on retroviral vectors produced by cell lines that are resistant to lysis by human serum. These vectors are designed to be resistant to inactivation by human serum, which enhances their effectiveness as in vivo gene delivery vehicles. The retroviral vectors are produced in various cell lines, including HOS, Mv-1-Lu, HT1080, TE671, and human 293 cell lines, as well as cell lines derived from them. This innovative approach is crucial for improving the reliability and safety of gene therapy applications.

Career Highlights

Throughout his career, Michael has worked with various organizations, including Genetic Therapy, Inc. His expertise in retroviral vector technology has positioned him as a key figure in the field of gene therapy. His contributions have paved the way for advancements in how genetic material can be delivered to target cells effectively.

Collaborations

Michael has collaborated with notable individuals in the field, including Robin Anthony Weiss and Yasuhiro Takeuchi. These partnerships have further enriched his research and development efforts, leading to innovative solutions in gene therapy.

Conclusion

Michael Pensiero's work in retroviral vector technology exemplifies the impact of innovation in the medical field. His patents and collaborations highlight the importance of advancing gene delivery systems for future therapeutic applications.